CN111303021A - 一种磺胺类胆碱离子液体及其制备方法与应用 - Google Patents
一种磺胺类胆碱离子液体及其制备方法与应用 Download PDFInfo
- Publication number
- CN111303021A CN111303021A CN202010184863.4A CN202010184863A CN111303021A CN 111303021 A CN111303021 A CN 111303021A CN 202010184863 A CN202010184863 A CN 202010184863A CN 111303021 A CN111303021 A CN 111303021A
- Authority
- CN
- China
- Prior art keywords
- ionic liquid
- choline
- sulfonamide
- sulfanilamide
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/40—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton with quaternised nitrogen atoms bound to carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C07D261/16—Benzene-sulfonamido isoxazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
供试菌 | 空白对照(mm) | 磺胺异噁唑(mm) | 离子液体(mm) |
大肠杆菌 | 5 | 6 | 6 |
肺炎球菌 | 5 | 10 | 19 |
沙门氏菌 | 5 | 13 | 20 |
葡萄球菌 | 5 | 6 | 8 |
链球菌 | 5 | 12 | 21 |
布氏杆菌 | 5 | 7 | 9 |
结核杆菌 | 5 | 6 | 7 |
供试菌 | 空白对照(mm) | 磺胺甲噁唑(mm) | 离子液体(mm) |
大肠杆菌 | 5 | 6 | 7 |
肺炎球菌 | 5 | 11 | 18 |
沙门氏菌 | 5 | 12 | 19 |
葡萄球菌 | 5 | 6 | 7 |
链球菌 | 5 | 12 | 19 |
布氏杆菌 | 5 | 8 | 10 |
结核杆菌 | 5 | 7 | 8 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010184863.4A CN111303021B (zh) | 2020-03-17 | 2020-03-17 | 一种磺胺类胆碱离子液体及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010184863.4A CN111303021B (zh) | 2020-03-17 | 2020-03-17 | 一种磺胺类胆碱离子液体及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111303021A true CN111303021A (zh) | 2020-06-19 |
CN111303021B CN111303021B (zh) | 2021-10-29 |
Family
ID=71151146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010184863.4A Active CN111303021B (zh) | 2020-03-17 | 2020-03-17 | 一种磺胺类胆碱离子液体及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111303021B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103547584A (zh) * | 2011-06-17 | 2014-01-29 | 流体公司 | 利用碳酸二烷基酯季铵化来合成杂离子化合物 |
US20140135218A1 (en) * | 2010-11-03 | 2014-05-15 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
CN105481782A (zh) * | 2015-12-25 | 2016-04-13 | 浙江工业大学 | 一种磺胺喹噁啉的制备方法 |
-
2020
- 2020-03-17 CN CN202010184863.4A patent/CN111303021B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140135218A1 (en) * | 2010-11-03 | 2014-05-15 | Dow Agrosciences Llc | Pesticidal compositions and processes related thereto |
CN103547584A (zh) * | 2011-06-17 | 2014-01-29 | 流体公司 | 利用碳酸二烷基酯季铵化来合成杂离子化合物 |
CN105481782A (zh) * | 2015-12-25 | 2016-04-13 | 浙江工业大学 | 一种磺胺喹噁啉的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111303021B (zh) | 2021-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111057164B (zh) | 一种胍基壳聚糖季铵盐抗菌剂的制备方法 | |
CN102229580A (zh) | 新型截短侧耳素衍生物、其制备方法及其医药用途 | |
CN111303021B (zh) | 一种磺胺类胆碱离子液体及其制备方法与应用 | |
CN103288857B (zh) | 沙拉沙星金属配合物及其制备方法 | |
JPS63122681A (ja) | ノルフロキサシンの水溶性付加物 | |
CN110590885A (zh) | 20-取代-5-o-碳霉胺糖基-泰乐内酯衍生物 | |
CN108033897A (zh) | 一种萘酰肼类化合物及其制备方法 | |
CN111909059B (zh) | 具有抑菌效果的Cu-二甲双胍配合物、其晶体结构以及制备方法和应用 | |
Varshney et al. | Synthesis of nitroimidazole derived oxazolidinones as antibacterial agents | |
CN103450095A (zh) | 一种磺胺间甲氧嘧啶汞及其制备方法 | |
CN107619478A (zh) | 一种聚四氢嘧啶杂环抗菌聚合物及其制备方法 | |
CN109350619B (zh) | 氨基取代的夫西地酸衍生物在制备抗真菌药物中的应用 | |
CN104774230B (zh) | 一种提高磷酸泰乐菌素稳定性的方法 | |
CN110878061B (zh) | 一种2-芳基取代的苯并噁唑啉类化合物及其合成方法与应用 | |
CN110885313B (zh) | 一种抗菌活性四苯基吡唑化合物及其制备方法与应用 | |
CN102180809B (zh) | 截短侧耳素的水杨酰胺醚化合物及其制备方法 | |
CN110204559A (zh) | 一种含咔唑基三唑并噻二唑衍生物及其制备方法 | |
DE2634358A1 (de) | 2,4-diamino-5-benzylpyrimidine, verfahren zu ihrer herstellung und arzneipraeparate | |
CN116640238B (zh) | 一种胍基吡啶壳聚糖鎓盐及其制备方法和应用 | |
CN112876421B (zh) | 杂多酸-磺胺嘧啶杂化化合物及其制备方法与应用 | |
Rogers | The antimetabolite concept in drug design | |
US3862315A (en) | Tetraamidino derivatives of antibiotic em-49 | |
CN117304241B (zh) | 一种大环内酯类化合物及其制备方法与应用 | |
CN102336722A (zh) | 双取代噻二唑及其制备方法和用途 | |
CN110655464B (zh) | 一种含氧乙酸结构的查尔酮类化合物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211015 Address after: 519000 101, building 5, Longyuan intelligent industrial park, No. 2, hagongda Road, Tangjiawan Town, high tech Zone, Zhuhai City, Guangdong Province Applicant after: ZHUHAI INSTITUTE OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES Co.,Ltd. Applicant after: Zhongke Xuanjia Medical Care (Zhuhai) Health Technology Co.,Ltd. Address before: 519000 12-storey factory building of Zone A, No. 1 Gangle Road, Tangjiawan Town, Zhuhai High-tech Zone, Guangdong Province Applicant before: ZHUHAI INSTITUTE OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES Co.,Ltd. Applicant before: Zhuhai Xuan Jiajunhang Health Industry Development Co.,Ltd. |